Hikma Pharmaceuticals PLC Free Cash Flow Generation Index
Hikma Pharmaceuticals PLC free cash flow generation index. Hikma Pharmaceuticals PLC (HIK) has a Free Cash Flow Generation Index of 0.58x as of June 2025. Free cash flow of GBX93.00 Million represents 1% of operating cash flow (GBX161.00 Million). Check Hikma Pharmaceuticals PLC liquidity resilience to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Hikma Pharmaceuticals PLC (2002–2024)
Free cash flow generation index of Hikma Pharmaceuticals PLC from 2002 to 2024. Historical FCF Generation Index trend for Hikma Pharmaceuticals PLC across 23 annual periods. Explore Hikma Pharmaceuticals PLC capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Hikma Pharmaceuticals PLC Free Cash Flow Generation Index by Year (2002–2024)
Hikma Pharmaceuticals PLC free cash flow generation index by year from 2002 to 2024. Year-by-year Free Cash Flow Generation Index for Hikma Pharmaceuticals PLC. For the full cash flow conversion analysis, see cash efficiency ratio of Hikma Pharmaceuticals PLC.
| Year | FCG Index | Free Cash Flow (GBX) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | GBX399.00 Million | GBX564.00 Million | GBX165.00 Million | ▼ -2.0% |
| 2023 | 0.72x | GBX439.00 Million | GBX608.00 Million | GBX169.00 Million | ▲ +25.5% |
| 2022 | 0.58x | GBX305.00 Million | GBX530.00 Million | GBX225.00 Million | ▼ -10.2% |
| 2021 | 0.64x | GBX409.00 Million | GBX638.00 Million | GBX229.00 Million | ▲ +23.9% |
| 2020 | 0.52x | GBX240.00 Million | GBX464.00 Million | GBX224.00 Million | ▼ -14.6% |
| 2019 | 0.61x | GBX286.00 Million | GBX472.00 Million | GBX186.00 Million | ▼ -19.3% |
| 2018 | 0.75x | GBX323.00 Million | GBX430.00 Million | GBX107.00 Million | ▼ -1.0% |
| 2017 | 0.76x | GBX336.00 Million | GBX443.00 Million | GBX107.00 Million | ▲ +30.0% |
| 2016 | 0.58x | GBX171.00 Million | GBX293.00 Million | GBX122.00 Million | ▼ -24.8% |
| 2015 | 0.78x | GBX284.00 Million | GBX366.00 Million | GBX82.00 Million | ▼ -1.3% |
| 2014 | 0.79x | GBX334.00 Million | GBX425.00 Million | GBX91.00 Million | ▼ -4.7% |
| 2013 | 0.82x | GBX278.00 Million | GBX337.00 Million | GBX59.00 Million | ▲ +63.4% |
| 2012 | 0.50x | GBX91.97 Million | GBX182.16 Million | GBX90.19 Million | ▲ +110.3% |
| 2011 | 0.24x | GBX24.64 Million | GBX102.64 Million | GBX78.00 Million | ▼ -61.1% |
| 2010 | 0.62x | GBX85.59 Million | GBX138.79 Million | GBX53.20 Million | ▼ -0.1% |
| 2009 | 0.62x | GBX65.14 Million | GBX105.52 Million | GBX40.38 Million | ▲ +567.2% |
| 2008 | -0.13x | GBX-7.65 Million | GBX57.87 Million | GBX65.52 Million | ▲ +52.0% |
| 2007 | -0.28x | GBX-11.87 Million | GBX43.12 Million | GBX54.99 Million | ▲ +63.2% |
| 2006 | -0.75x | GBX-22.45 Million | GBX29.99 Million | GBX52.44 Million | ▼ -380.5% |
| 2005 | 0.27x | GBX8.73 Million | GBX32.71 Million | GBX23.98 Million | ▼ -23.9% |
| 2004 | 0.35x | GBX11.51 Million | GBX32.84 Million | GBX21.33 Million | ▼ -64.9% |
| 2003 | 1.00x | GBX18.35 Million | GBX18.35 Million | GBX0.00 | ▲ +0.0% |
| 2002 | 1.00x | GBX14.35 Million | GBX14.35 Million | GBX0.00 | — |